Modifizierter Antikörper

European patent · EP2862878 · Deleted

Register entry

Publication number
EP2862878
Application number
EP14195614
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 25, 2004
Published
Apr 22, 2015
Granted
Nov 2, 2022
Deleted
Sep 23, 2023
Reason
Annual fee unpaid
IPC classes
C07K 16/46 (2006.01)
Priority
US 450134 P 25.02.2003
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 23, 2023

    Deleted, fee unpaid

    Published in Swissreg on 23.09.2023

  2. Sep 13, 2023

    Change

    Published in Swissreg on 13.09.2023

  3. Nov 2, 2022

    Granted

    Published in Swissreg on 02.11.2022

Parties

Holder

Nykode Therapeutics ASA

Gaustadalléen 21, 0349 Oslo, NO

Inventor

Bogen, Bjarne

1367 Snarøya, NO

Fredriksen, Agnete Brunsvik

2005 Rællingen, NO

Sandlie, Inger

0752 Oslo, NO

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.